Response by Piccini et al to Letters Regarding Article, "polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation"

J.P. Piccini; A.S. Hellkamp; J.B. Washam; R.C. Becker; G. Breithardt; S.D. Berkowitz; J.L. Halperin; Graeme J. Hankey; W. Hacke; K.W. Mahaffey; C.C. Nessel; D.E. Singer; K.A.A. Fox; M.R. Patel

doi:10.1161/CIRCULATIONAHA.116.022737

Response by Piccini et al to Letters Regarding Article, "polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation"

J.P. Piccini, A.S. Hellkamp, J.B. Washam, R.C. Becker, G. Breithardt, S.D. Berkowitz, J.L. Halperin, Graeme J. Hankey, W. Hacke, K.W. Mahaffey, C.C. Nessel, D.E. Singer, K.A.A. Fox, M.R. Patel

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	e7-e8
Journal	Circulation
Volume	134
Issue number	2
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.116.022737
Publication status	Published - Jul 2016

Access to Document

10.1161/CIRCULATIONAHA.116.022737

Cite this

Piccini, J. P., Hellkamp, A. S., Washam, J. B., Becker, R. C., Breithardt, G., Berkowitz, S. D., Halperin, J. L., Hankey, G. J., Hacke, W., Mahaffey, K. W., Nessel, C. C., Singer, D. E., Fox, K. A. A., & Patel, M. R. (2016). Response by Piccini et al to Letters Regarding Article, "polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation". Circulation, 134(2), e7-e8. https://doi.org/10.1161/CIRCULATIONAHA.116.022737

Piccini, J.P. ; Hellkamp, A.S. ; Washam, J.B. ; Becker, R.C. ; Breithardt, G. ; Berkowitz, S.D. ; Halperin, J.L. ; Hankey, Graeme J. ; Hacke, W. ; Mahaffey, K.W. ; Nessel, C.C. ; Singer, D.E. ; Fox, K.A.A. ; Patel, M.R. / Response by Piccini et al to Letters Regarding Article, "polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation". In: Circulation. 2016 ; Vol. 134, No. 2. pp. e7-e8.

@article{5237cde58092478b8a9cbd317e44a81e,

title = "Response by Piccini et al to Letters Regarding Article, {"}polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation{"}",

author = "J.P. Piccini and A.S. Hellkamp and J.B. Washam and R.C. Becker and G. Breithardt and S.D. Berkowitz and J.L. Halperin and Hankey, {Graeme J.} and W. Hacke and K.W. Mahaffey and C.C. Nessel and D.E. Singer and K.A.A. Fox and M.R. Patel",

year = "2016",

month = jul,

doi = "10.1161/CIRCULATIONAHA.116.022737",

language = "English",

volume = "134",

pages = "e7--e8",

journal = "Circulation (Baltimore)",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

number = "2",

}

Piccini, JP, Hellkamp, AS, Washam, JB, Becker, RC, Breithardt, G, Berkowitz, SD, Halperin, JL, Hankey, GJ, Hacke, W, Mahaffey, KW, Nessel, CC, Singer, DE, Fox, KAA & Patel, MR 2016, 'Response by Piccini et al to Letters Regarding Article, "polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation"', Circulation, vol. 134, no. 2, pp. e7-e8. https://doi.org/10.1161/CIRCULATIONAHA.116.022737

Response by Piccini et al to Letters Regarding Article, "polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation". / Piccini, J.P.; Hellkamp, A.S.; Washam, J.B.; Becker, R.C.; Breithardt, G.; Berkowitz, S.D.; Halperin, J.L.; Hankey, Graeme J.; Hacke, W.; Mahaffey, K.W.; Nessel, C.C.; Singer, D.E.; Fox, K.A.A.; Patel, M.R.

In: Circulation, Vol. 134, No. 2, 07.2016, p. e7-e8.

Research output: Contribution to journal › Letter

TY - JOUR

T1 - Response by Piccini et al to Letters Regarding Article, "polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation"

AU - Piccini, J.P.

AU - Hellkamp, A.S.

AU - Washam, J.B.

AU - Becker, R.C.

AU - Breithardt, G.

AU - Berkowitz, S.D.

AU - Halperin, J.L.

AU - Hankey, Graeme J.

AU - Hacke, W.

AU - Mahaffey, K.W.

AU - Nessel, C.C.

AU - Singer, D.E.

AU - Fox, K.A.A.

AU - Patel, M.R.

PY - 2016/7

Y1 - 2016/7

U2 - 10.1161/CIRCULATIONAHA.116.022737

DO - 10.1161/CIRCULATIONAHA.116.022737

M3 - Letter

C2 - 27400902

VL - 134

SP - e7-e8

JO - Circulation (Baltimore)

JF - Circulation (Baltimore)

SN - 0009-7322

IS - 2

ER -

Piccini JP, Hellkamp AS, Washam JB, Becker RC, Breithardt G, Berkowitz SD et al. Response by Piccini et al to Letters Regarding Article, "polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation". Circulation. 2016 Jul;134(2):e7-e8. https://doi.org/10.1161/CIRCULATIONAHA.116.022737